Böhm N, Noltemeyer N
Histochemistry. 1981;72(1):63-74. doi: 10.1007/BF00496780.
Phenobarbital was injected intraperitoneally into male white NMRI mice aged 0.5, 1. 1.5, 3, 6 and 12 months at a dose of 120 mg/kg body weight for 10 consecutive days. The 0.5 month-old mice did not tolerate the phenobarbital dose and died. The experimental animals and one of the controls were sacrificed 1, 3, 5, 10, 15 and 20 days after phenobarbital administration was started. Liver weights were recorded and liver cells were isolated. The number of nuclei per cell was determined and the DNA-content of each single nucleus was measured by Feulgen fluorescence cytophotometry. Liver weights showed an increase of 25--30% during phenobarbital treatment and returned slowly to lower values after cessation of drug application. The hepatic enlargement was accompanied by an excessive and likewise reversible nuclear and whole cell DNA-polyploidization, i.e. polyploidization beyond the physiological age-dependent ploidy level; for example, mean values of 7.7 c per nucleus (versus 4.2 c in the controls) and 14.3 c for whole liver cells (versus 7.5 c in the controls) were found in 3 months-old animals after 5 days of treatment. As with the induction of microsomal enzymes, the augmentation of smooth endoplasmic reticulum, and the increase of RNA- and protein-synthesis, excessive DNA-polyploidization of liver cell nuclei appears to be an expression of hepatocellular hypertrophy due to the functional or metabolic stress imposed upon the liver by large quantities of phenobarbital. After cessation of drug administration the abnormally high ploidy cells are eliminated - probably by necrobiosis - and the liver cells return to their normal age-dependent DNA-ploidy level. The liver cells of the one-month-old animals revealed the physiological polyploidization to be slightly inhibited. This is probably due to some toxic effect of phenobarbital. Phenobarbital did not alter the number of nuclei per liver cell.
将苯巴比妥以120毫克/千克体重的剂量连续10天腹腔注射给0.5、1、1.5、3、6和12月龄的雄性白色NMRI小鼠。0.5月龄的小鼠无法耐受该苯巴比妥剂量并死亡。在开始给予苯巴比妥后的1、3、5、10、15和20天,处死实验动物和其中一组对照。记录肝脏重量并分离肝细胞。测定每个细胞的细胞核数量,并通过福尔根荧光细胞光度法测量每个单个细胞核的DNA含量。在苯巴比妥治疗期间,肝脏重量增加了25%至30%,停药后缓慢恢复到较低值。肝脏肿大伴随着细胞核和整个细胞DNA多倍体化过度且同样可逆,即多倍体化超过了生理年龄依赖性倍性水平;例如,在3月龄动物治疗5天后,发现每个细胞核的平均值为7.7 c(对照组为4.2 c),整个肝细胞的平均值为14.3 c(对照组为7.5 c)。与微粒体酶的诱导、滑面内质网的增加以及RNA和蛋白质合成的增加一样,肝细胞细胞核的过度DNA多倍体化似乎是由于大量苯巴比妥对肝脏施加的功能或代谢应激导致肝细胞肥大的一种表现。停药后,异常高倍性的细胞可能通过渐进性坏死被清除,肝细胞恢复到其正常的年龄依赖性DNA倍性水平。1月龄动物的肝细胞显示出生理多倍体化略有抑制。这可能是由于苯巴比妥的某种毒性作用。苯巴比妥没有改变每个肝细胞的细胞核数量。